These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5890327)

  • 1. [The antitumor effect of phenazine derivatives containing alkylating group].
    Yoshioka I; Ueda K; Ishiguro M; Hayashi M; Mizuno D
    Yakugaku Zasshi; 1965 Aug; 85(8):725-30. PubMed ID: 5890327
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the anticancer activity of phenazine derivatives.
    Hano K; Iwata H; Nakajima K
    Chem Pharm Bull (Tokyo); 1965 Feb; 13(2):107-13. PubMed ID: 5863454
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitumor activity of phenazine di-N-oxides. II.
    Matsuura S; Sunagawa N; Katagiri K; Endo H; Tada M
    Sci Rep Res Inst Tohoku Univ Med; 1969 Oct; 16(1):15-7. PubMed ID: 5375993
    [No Abstract]   [Full Text] [Related]  

  • 4. A new antitumour agent: phenazathionium-mustard salt.
    Csaba G; Körösi J
    Neoplasma; 1968; 15(4):443-5. PubMed ID: 5684468
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on antitumor activity of phenazine derivatives against S 180 and C 63 in mice. II.
    Endo H; Tada M; Katagiri K
    Sci Rep Res Inst Tohoku Univ Med; 1966 Jun; 13(1):12-4. PubMed ID: 5963576
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on antitumor activity of phenazine derivatives against s 180 and c 63 in mice (3).
    Endo H; Tada M; Katagiri K
    Sci Rep Res Inst Tohoku Univ Med; 1966 Dec; 13(3):197-9. PubMed ID: 5984020
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on antitumor activity of phenazine derivatives against S 180 in mice. 8.
    Endo H; Tada M; Katagiri K
    Sci Rep Res Inst Tohoku Univ Med; 1969 Oct; 16(1):18-26. PubMed ID: 5375994
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antitumor activities of 43 pyridine and pyridone derivatives].
    Tomizawa H; Hongo H; Agatsuma T; Yamada M; Hirokawa Y
    Yakugaku Zasshi; 1966 May; 86(5):433-7. PubMed ID: 6011008
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on anti-tumor activity of isoquinoline derivatives. I. On the relationship between chemical constituion and antitumor (HeLa and Ehrlich) activity].
    Arai Y; Enomoto K
    Yakugaku Zasshi; 1968 Jan; 88(1):44-54. PubMed ID: 5692285
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of various antitumor agents on intracerebrally inoculated Ehrlich ascites carcinoma in mice (author's transl)].
    Zhou JX; He GH; Tao LX; Xu B
    Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):256-61. PubMed ID: 6462026
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitumor activity of aromatic acyl derivatives of amino acids.
    Lichtenstein N; Grossowicz N; Schlesinger M
    Isr J Med Sci; 1977 Mar; 13(3):316-20. PubMed ID: 852979
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo Anticancer Effects of a Novel 9-Phenyldibenzo[a,c]phenazin-9-ium Cation and Its Ligands.
    Das S; Banerjee K; Biswas MK; Bhadra R; Ghosh P; Choudhuri SK
    Chemotherapy; 2014; 60(4):261-6. PubMed ID: 25926067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical and biochemical studies on carbohydrate esters. II. Antitumor activity of saturated fatty acids and their ester derivatives against Ehrlich ascites carcinoma.
    Nishikawa Y; Okabe M; Yoshimoto K; Kurono G; Fukuoka F
    Chem Pharm Bull (Tokyo); 1976 Mar; 24(3):387-93. PubMed ID: 1021244
    [No Abstract]   [Full Text] [Related]  

  • 14. Mixed bifunctionality. II. Relation of antitumor activity to structure in alkylating agents derived from polynuclear aromatic hydrocarbons.
    Peck RM; O'Connell AP; Creech HJ
    J Med Chem; 1970 Mar; 13(2):284-8. PubMed ID: 5418503
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitumor effect of implanted ethylene-vinyl alcohol copolymer matrices containing anticancer agents on Ehrlich ascites carcinoma and P388 leukemia in mice.
    Miyazaki S; Takeuchi S; Hou WM; Hashiguchi N; Yokouchi C; Takada M; Hosokawa M; Koga Y; Kobayashi H
    Chem Pharm Bull (Tokyo); 1985 Jun; 33(6):2490-8. PubMed ID: 4064208
    [No Abstract]   [Full Text] [Related]  

  • 16. [Correlations between the chemical structure of Mannich bases with and without nitrogen mustard groups and their cytostatic effect on Ehrlich ascites carcinoma in albino mice].
    Werner W; Jungstand W; Gutsche W
    Arzneimittelforschung; 1970 Feb; 20(2):246-9. PubMed ID: 5467470
    [No Abstract]   [Full Text] [Related]  

  • 17. The first organoantimony(III) compounds possessing antitumor properties: diphenylantimony(III) derivatives of dithiophosphorus ligands.
    Silvestru C; Socaciu C; Bara A; Haiduc I
    Anticancer Res; 1990; 10(3):803-4. PubMed ID: 2369094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STUDIES ON ANTITUMOR SUBSTANCES. I. ANTITUMOR EFFECT OF QUINONE DERIVATIVES CONTAINING AN ALKYLATING GROUP.
    HAYASHI S; UEKI H; UEKI Y
    Gan; 1963 Dec; 54():381-90. PubMed ID: 14099936
    [No Abstract]   [Full Text] [Related]  

  • 19. [Derivatives of 2-amino-1,4-naphthoquinone as carcinostatic agents].
    Petersen S; Gauss W; Kiehne H; Jühling L
    Z Krebsforsch; 1969; 72(2):162-75. PubMed ID: 4239415
    [No Abstract]   [Full Text] [Related]  

  • 20. [The antitumor activity of 4,6-dinitroquinoline 1-oxide].
    Okamoto T; Hasegawa Y; Kinoshita T; Ishiguro M; Mizuno D
    Yakugaku Zasshi; 1965 Aug; 85(8):720-4. PubMed ID: 5890326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.